• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Different intra- and inter-molecular hydrogen-bonding patterns in (3,4a,8a)-2-[(2,3)-3-(2,5--benzamido)-2-(2,5--benzo-yloxy)-4-phenyl-butyl]---butyldeca-hydro-iso-quinoline-3-carboxamides ( = H or Cl): compounds with moderate aspartyl protease inhibition activity.

作者信息

Cunico Wilson, Ferreira Maria de Lourdes G, Wardell James L, Harrison William T A

机构信息

Departamento de Química Orgânica, Universidade Federal de Pelotas (UFPel), Campus Universitário, s/n, Caixa Postal 354, 96010-900 Pelotas, RS, Brazil.

Instituto de Tecnologia em Fármacos - Farmanguinhos, Fiocruz. R. Sizenando, Nabuco, 100, Manguinhos, 21041-250, Rio de Janeiro, RJ, Brazil.

出版信息

Acta Crystallogr E Crystallogr Commun. 2017 May 31;73(Pt 6):913-917. doi: 10.1107/S2056989017007800. eCollection 2017 Jun 1.

DOI:10.1107/S2056989017007800
PMID:28638658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5458323/
Abstract

The crystal structures of (3,4a,8a)-2-[(2,3)-3-benzamido-2-benzo-yloxy-4-phenyl-but-yl]---butyldeca-hydro-iso-quinoline-3-carboxamide, CHNO, (I), and (3,4a,8a)-2-[(2,3)-3-(2,5-di-chloro-benzamido)-2-(2,5-di-chloro-benzo-yloxy)-4-phenyl-but-yl]---butyldeca-hydro-iso-quinoline-3-carboxamide, CHClNO, (II), are described. Despite their chemical similarity, they adopt different conformations in the solid state: (I) features a bifurcated intra-molecular N-H⋯(N,O) hydrogen bond from the -butylamide NH group to the piperidine N atom and the benzoate O atom, whereas (II) has an intra-molecular N-H⋯O link from the benzamide NH group to the -butyl-amide O atom. In the crystal of (I), mol-ecules are linked by (4) amide N-H⋯O hydrogen bonds into chains propagating in the [010] direction, with both donor and acceptor parts of the benzamide group. In the extended structure of (II), (11) N-H⋯O chains propagating in the [010] direction arise, with the donor being the -butylamide NH group and the acceptor being the O atom of the benzamide group.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9d8/5458323/76119430a5c4/e-73-00913-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9d8/5458323/8b396ae559fe/e-73-00913-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9d8/5458323/edb04f33a2f0/e-73-00913-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9d8/5458323/2f29a2eacdbc/e-73-00913-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9d8/5458323/76119430a5c4/e-73-00913-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9d8/5458323/8b396ae559fe/e-73-00913-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9d8/5458323/edb04f33a2f0/e-73-00913-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9d8/5458323/2f29a2eacdbc/e-73-00913-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9d8/5458323/76119430a5c4/e-73-00913-fig4.jpg

相似文献

1
Different intra- and inter-molecular hydrogen-bonding patterns in (3,4a,8a)-2-[(2,3)-3-(2,5--benzamido)-2-(2,5--benzo-yloxy)-4-phenyl-butyl]---butyldeca-hydro-iso-quinoline-3-carboxamides ( = H or Cl): compounds with moderate aspartyl protease inhibition activity.
Acta Crystallogr E Crystallogr Commun. 2017 May 31;73(Pt 6):913-917. doi: 10.1107/S2056989017007800. eCollection 2017 Jun 1.
2
Crystal structure and absolute configuration of (3S,4aS,8aS)-N-tert-butyl-2-[(S)-3-(2-chloro-4-nitro-benzamido)-2-hy-droxy-prop-yl]deca-hydro-isoquinoline-3-carboxamide and (3S,4aS,8aS)-N-tert-butyl-2-{(S)-2-[(S)-1-(2-chloro-4-nitro-benzoyl)pyrrolidin-2-yl]-2-hy-droxy-eth-yl}deca-hydro-iso-quinoline-3-carboxamide.(3S,4aS,8aS)-N-叔丁基-2-[(S)-3-(2-氯-4-硝基苯甲酰胺基)-2-羟基丙基]十氢异喹啉-3-甲酰胺和(3S,4aS,8aS)-N-叔丁基-2-{ (S)-2-[(S)-1-(2-氯-4-硝基苯甲酰基)吡咯烷-2-基]-2-羟基乙基}十氢异喹啉-3-甲酰胺的晶体结构和绝对构型
Acta Crystallogr E Crystallogr Commun. 2015 Oct 31;71(Pt 11):1401-7. doi: 10.1107/S2056989015020046. eCollection 2015 Nov 1.
3
Crystal structure of 2-[(1R,2R,4aS,8aS)-2-hy-droxy-2,5,5,8a-tetra-methyl-deca-hydro-naphthalen-1-yl]-N-(o-tol-yl)acetamide.
Acta Crystallogr E Crystallogr Commun. 2015 Sep 26;71(Pt 10):o788-9. doi: 10.1107/S2056989015017600. eCollection 2015 Oct 1.
4
Crystal structure and Hirshfeld surface analysis of 4'-(2-chloro-phen-yl)-1'-methyl-3''-phenyl-7'',8''-di-hydro-5''-di-spiro-[indoline-3,2'-pyrrolidine-3',6''-iso-quinoline]-2,5''-dione.4'-(2-氯苯基)-1'-甲基-3''-苯基-7'',8''-二氢-5''-二螺-[吲哚啉-3,2'-吡咯烷-3',6''-异喹啉]-2,5''-二酮的晶体结构与 Hirshfeld 表面分析
Acta Crystallogr E Crystallogr Commun. 2018 Apr 12;74(Pt 5):660-663. doi: 10.1107/S2056989018005455. eCollection 2018 May 1.
5
Crystal structures and anti-oxidant capacity of ()-5-benz-yloxy-2-{[(4-chloro-phen-yl)imino]-meth-yl}phenol and ()-5-benz-yloxy-2-({[2-(1-indol-3-yl)eth-yl]iminium-yl}meth-yl)phenolate.()-5-苄氧基-2-{[(4-氯苯基)亚氨基]-甲基}苯酚和()-5-苄氧基-2-({[2-(1-吲哚-3-基)乙基]亚胺基}甲基)苯酚盐的晶体结构与抗氧化能力
Acta Crystallogr E Crystallogr Commun. 2018 Mar 9;74(Pt 4):478-482. doi: 10.1107/S2056989018003687. eCollection 2018 Apr 1.
6
Crystal structure of (3*,4*)-4-fluoro-3-(4-meth-oxy-phen-yl)-1-oxo-2-phenyl-1,2,3,4-tetra-hydro-iso-quinoline-4-carb-oxy-lic acid.(3*,4*)-4-氟-3-(4-甲氧基-苯基)-1-氧代-2-苯基-1,2,3,4-四氢异喹啉-4-羧酸的晶体结构
Acta Crystallogr E Crystallogr Commun. 2017 May 23;73(Pt 6):867-870. doi: 10.1107/S2056989017007186. eCollection 2017 Jun 1.
7
Crystal structures and the Hirshfeld surface analysis of -4-nitro-'-(-chloro, - and -methyl-benzyl-idene)benzene-sulfono-hydrazides.-4-硝基-'-(-氯、-甲基-亚苄基)苯磺酰肼的晶体结构与 Hirshfeld 表面分析
Acta Crystallogr E Crystallogr Commun. 2018 Nov 6;74(Pt 12):1710-1716. doi: 10.1107/S2056989018015207. eCollection 2018 Dec 1.
8
Syntheses, characterizations, crystal structures and Hirshfeld surface analyses of methyl 4-[4-(di-fluorometh-oxy)phen-yl]-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate, isopropyl 4-[4-(di-fluoro-meth-oxy)phen-yl]-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate and -butyl 4-[4-(di-fluoro-meth-oxy)phen-yl]-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate.4-[4-(二氟甲氧基)苯基]-2,7,7-三甲基-5-氧代-1,4,5,6,7,8-六氢喹啉-3-羧酸甲酯、4-[4-(二氟甲氧基)苯基]-2,6,6-三甲基-5-氧代-1,4,5,6,7,8-六氢喹啉-3-羧酸异丙酯和4-[4-(二氟甲氧基)苯基]-2,6,6-三甲基-5-氧代-1,4,5,6,7,8-六氢喹啉-3-羧酸丁酯的合成、表征、晶体结构及 Hirshfeld 表面分析
Acta Crystallogr E Crystallogr Commun. 2024 Feb 8;80(Pt 3):281-288. doi: 10.1107/S2056989024001233. eCollection 2024 Mar 1.
9
Crystal structures of N-tert-butyl-3-(4-fluoro-phenyl)-5-oxo-4-[2-(tri-fluoro-meth-oxy)phen-yl]-2,5-di-hydro-furan-2-carboxamide and 4-(2H-1,3-benzodioxol-5-yl)-N-cyclo-hexyl-5-oxo-3-[4-(tri-fluoro-meth-yl)phen-yl]-2,5-di-hydro-furan-2-carboxamide.N-叔丁基-3-(4-氟苯基)-5-氧代-4-[2-(三氟甲氧基)苯基]-2,5-二氢呋喃-2-甲酰胺和4-(2H-1,3-苯并二氧杂环戊烯-5-基)-N-环己基-5-氧代-3-[4-(三氟甲基)苯基]-2,5-二氢呋喃-2-甲酰胺的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 Jan 24;71(Pt 2):199-202. doi: 10.1107/S2056989015000936. eCollection 2015 Feb 1.
10
Crystal structures of 2-(4-nitro-phen-yl)-3-phenyl-2,3-di-hydro-4H-1,3-benzo-thia-zin-4-one and 2-(2-nitro-phen-yl)-3-phenyl-2,3-di-hydro-4H-1,3-benzo-thia-zin-4-one.2-(4-硝基苯基)-3-苯基-2,3-二氢-4H-1,3-苯并噻嗪-4-酮和2-(2-硝基苯基)-3-苯基-2,3-二氢-4H-1,3-苯并噻嗪-4-酮的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 Mar 25;71(Pt 4):414-7. doi: 10.1107/S2056989015004545. eCollection 2015 Apr 1.

本文引用的文献

1
The Cambridge Structural Database.剑桥结构数据库。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016 Apr;72(Pt 2):171-9. doi: 10.1107/S2052520616003954. Epub 2016 Apr 1.
2
Fighting malaria: structure-guided discovery of nonpeptidomimetic plasmepsin inhibitors.抗疟:基于结构的非肽拟肽酶抑制剂发现。
J Med Chem. 2015 Jul 9;58(13):5151-63. doi: 10.1021/jm5014133. Epub 2015 Mar 17.
3
Aspartic protease inhibitors containing tertiary alcohol transition-state mimics.含有叔醇过渡态模拟物的天冬氨酸蛋白酶抑制剂。
Eur J Med Chem. 2015 Jan 27;90:462-90. doi: 10.1016/j.ejmech.2014.11.036. Epub 2014 Nov 20.
4
Use of intensity quotients and differences in absolute structure refinement.强度商数的使用及绝对结构精修中的差异
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2013 Jun;69(Pt 3):249-59. doi: 10.1107/S2052519213010014. Epub 2013 May 17.
5
A short history of SHELX.SHELX简史。
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. doi: 10.1107/S0108767307043930. Epub 2007 Dec 21.
6
Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV.疟原虫天冬氨酸蛋白酶(血浆蛋白酶I、II和IV)的大环抑制剂。
Bioorg Med Chem. 2006 Apr 1;14(7):2197-208. doi: 10.1016/j.bmc.2005.11.003. Epub 2005 Nov 22.
7
Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II.针对疟原虫蛋白酶组织蛋白酶 I 和 II 的抑制剂的合成、生物学评估及建模研究。
Bioorg Med Chem. 2005 Sep 15;13(18):5371-90. doi: 10.1016/j.bmc.2005.06.048.
8
Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.恶性疟原虫及其他寄生原生动物的天冬氨酸蛋白酶作为药物靶点
Trends Parasitol. 2001 Nov;17(11):532-7. doi: 10.1016/s1471-4922(01)02037-2.